We are advising Charles River on the transaction

Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $470 million acquisition of Frontage Holdings Corporation’s bioanalysis and drug metabolism and pharmacokinetics (DMPK) businesses in Exton, Pennsylvania, with up to $75 million in additional performance-based consideration. Charles River has formed a consortium with Frontage’s controlling shareholder, Tigermed, and Chairman Dr. Song Li to take Frontage private, after which Charles River will retain the bioanalysis and DMPK businesses. The transaction is expected to close in the first half of 2027, subject to customary closing conditions, including shareholder and regulatory approvals.

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. The company helps clients improve and expedite the discovery, early-stage development and safe manufacture of new therapies.

Frontage is a global pharmaceutical development organization providing integrated, science-driven research and development services to the pharmaceutical and biotechnology industries. Headquartered in Exton, Pennsylvania, the company offers services spanning drug discovery, preclinical and clinical development, bioanalysis, DMPK and laboratory testing, helping clients advance new therapies through development. Frontage is listed on The Stock Exchange of Hong Kong.

The Davis Polk corporate team includes partner Michael Davis and associates Claire Fischer and Léonard Aeschlimann Perales. The Hong Kong corporate team includes partner Jason Xu, counsel Vanessa Chan and associate Calvin Lam. Partner William A. Curran is providing tax advice. Partner David R. Bauer and counsel Mikaela Dealissia are providing intellectual property and commercial transactions advice. Partner Hilary Dengel is providing finance advice. Partner Kyoko Takahashi Lin is providing executive compensation advice. Members of the Davis Polk team are based in the New York, Beijing and Hong Kong offices.